University Of Luebeck

At the University Of Luebeck, cardiovascular research focuses on conditions such as atherosclerotic cardiovascular disease, elevated Lp(a), and inflammatory cardiomyopathy. The studies are designed to evaluate new treatment approaches and better reduce the risk of serious heart-related events.

• Testing whether immunosuppressive therapy can improve heart function in chronic inflammatory cardiomyopathy
• Evaluating a new treatment approach to lower major cardiovascular events in people with elevated Lp(a)
• Assessing whether targeted therapies can improve outcomes in patients with high-risk cardiovascular disease

This work combines clinical care and research to advance treatment options for patients with complex heart and vascular diseases.

Digestive disease trials at this site examine non-alcoholic steatohepatitis and advanced pancreatic cancer. The research aims to improve liver health, refine treatment selection, and support better long-term outcomes for patients with serious gastrointestinal conditions.

• Studying whether semaglutide can improve liver tissue damage and reduce liver-related complications in NASH
• Investigating personalized chemotherapy selection after surgery for resected pancreatic ductal adenocarcinoma
• Exploring more effective treatment strategies for advanced cancers of the digestive tract

These studies address both chronic liver disease and aggressive gastrointestinal malignancies, with a strong focus on treatment effectiveness.

Research in immune-mediated diseases includes studies of neurodermatitis and lichen simplex chronicus. The goal is to improve symptom control, especially for persistent itching and skin inflammation that can be difficult to manage with standard care.

• Evaluating whether dupilumab can relieve itching and improve skin symptoms in adults with moderate-to-severe lichen simplex chronicus
• Studying new ways to better control chronic inflammatory skin disease
• Assessing treatment options for patients whose symptoms remain uncontrolled with topical therapies

These trials support a broader effort to improve everyday quality of life for people living with chronic allergic and inflammatory conditions.

Musculoskeletal research at the University Of Luebeck includes studies in patients undergoing elective hip arthroplasty. The main focus is on safer recovery after surgery and better prevention of postoperative complications.

• Testing whether a shorter course of anticoagulation is as effective as standard treatment after hip replacement
• Evaluating strategies to prevent venous thromboembolism during fast-track recovery after surgery
• Supporting enhanced recovery pathways for orthopedic patients

This research is aimed at improving postoperative safety while helping patients return to mobility sooner.

Oncology trials at this educational research site address pancreatic cancer and advanced stomach or gastroesophageal junction adenocarcinoma. The studies are focused on improving survival, comparing treatment options, and personalizing cancer care.

• Assessing whether treatment guided by genetic or molecular markers can improve outcomes after surgery for pancreatic ductal adenocarcinoma
• Comparing chemotherapy combinations for advanced gastroesophageal cancer after prior treatment failure
• Evaluating ways to make cancer therapy more effective for patients with limited treatment options

These investigations reflect a strong interest in precision oncology and better treatment selection for hard-to-treat cancers.

Metabolic research at the University Of Luebeck covers obesity, overweight, and type 2 diabetes. The trials are designed to test new therapies that may help with weight reduction and improve metabolic health.

• Evaluating whether a new therapy can reduce body weight in adults with obesity or overweight and type 2 diabetes
• Studying treatment approaches for metabolic disease that may also improve cardiovascular risk
• Exploring better options for long-term management of weight-related conditions

These studies aim to support more effective care for patients affected by metabolic disorders that often overlap with heart and liver disease.